Asuragen Raises $5M, Targeting $10M in Series C Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics shop Asuragen has raised $5 million toward a $10 million goal in its latest financing round.

In an e-mail to GenomeWeb Daily News, Asuragen Founder and CEO Matt Winkler confirmed the firm has closed the first $5 million of a $10 million Series C equity financing round, and added that the investment was made by an undisclosed "strategic venture investor."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.